CDMO
About us
Services

Boehringer Ingelheim - CDMO/CMO

As a part of the renowned Boehringer Ingelheim Group, their CDMO division offers comprehensive biopharmaceutical services. They specialize in the development and manufacturing of biologics, including monoclonal antibodies, recombinant proteins, and biosimilars. With a global presence and cutting-edge facilities, they provide end-to-end solutions from cell line development to commercial manufacturing.

Address: Binger Strasse 173, 55216, Ingelheim am Rhein
Germany
Germany Local time:

Strong heritage in pharmaceutical innovation and biotechnology.

Comprehensive range of services from early development to commercial supply.

Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.

Our services:

Drug Substance
Drug Product

Production scale:

large

Response time:

label.follow_us Follow us:
Established in:
1885

Drug Substance (CDMO/CRO)

Biologics
Biologics are complex medicines derived from living cells, used in treating diseases such as cancer, autoimmune disorders, and more. CDMOs specializing in biologics offer capabilities in cell line development, upstream/downstream processing, and sterile fill-finish.
Contact supplier

Replies slower than most

Peptides
Peptides are short chains of amino acids with therapeutic potential across endocrinology, oncology, and metabolic disorders. CDMOs offer synthesis, purification, and formulation services tailored to peptide APIs and drug products.
Contact supplier

Replies slower than most

Drug Product (CMO)

Biologic Products
Biologic products include complex therapies such as monoclonal antibodies and vaccines. CDMOs offer cell culture, protein expression, purification, and GMP manufacturing for commercial use.
Contact supplier

Replies slower than most

Contact Boehringer Ingelheim Group for Contract Services Expertise

Connect with Boehringer Ingelheim Group, a leading pharmaceutical company from Germany. They offer specialized Drug Substance (CDMO/CRO), Drug Product (CMO). Contact Boehringer Ingelheim Group for free and discover if they are the perfect partner for your pharmaceutical needs.

Drug Substance (CDMO/CRO)

Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.


Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.


Key Functions of Drug Substance CDMOs/CROs:


  • API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.

  • Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.

  • GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.

  • Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.

  • Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.


Explore Leading API CDMOs and CROs

Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.

Drug Product (CMO)

Drug Product CMOs focus on the manufacturing and packaging of finished pharmaceutical dosage forms. These contract partners provide scalable production solutions that meet global regulatory and quality standards, supporting pharma companies throughout the drug product lifecycle.


Pharmaoffer’s Drug Product CMO category includes providers capable of manufacturing oral solids, injectables, topical formulations, and more—whether for clinical trials or commercial distribution.


Key Functions of Drug Product CMOs:


  • Formulation Development: Supporting the transition from drug substance to drug product through formulation optimization and compatibility testing.

  • Clinical and Commercial Manufacturing: Offering pilot-scale to high-volume manufacturing for various dosage forms under GMP conditions.

  • Packaging and Serialization: Providing primary and secondary packaging with serialization and tamper-proof labeling to meet compliance requirements.

  • Regulatory Support: Ensuring that all production meets FDA, EMA, and ICH standards for drug product quality, safety, and traceability.

  • Flexible Production Lines: Handling diverse dosage forms including tablets, softgels, liquids, and sterile injectables.


Partner with Proven Drug Product CMOs

Through Pharmaoffer, discover CMOs that excel in drug product manufacturing. Whether you need small-scale batches or full commercial output, our platform connects you with the right partners for compliant, cost-effective solutions.

Boehringer Ingelheim


As a part of the renowned Boehringer Ingelheim Group, their CDMO division offers comprehensive biopharmaceutical services. They specialize in the development and manufacturing of biologics, including monoclonal antibodies, recombinant proteins, and biosimilars. With a global presence and cutting-edge facilities, they provide end-to-end solutions from cell line development to commercial manufacturing.